New research on stem cells provides hope for those suffering from vision loss due to degenerating or damaged retinal cells. In order to generate a large population of cells for vision repair, we first need to understand how these cells are formed in the developing embryo. Once we understand the extrinsic and intrinsic events involved, the conditions can be recreated in culture. These cells can also be employed to model degenerative diseases and to tailor treatment for patients before they lose vision.
In order to elucidate the parameters needed to generate retinal cells in culture, we need to first understand how the embryonic eye develops. The eye primordia, or the eye field, takes shape just posterior to the neural ridge in humans, mice and amphibians ( Fig. 1 , blue area). 1, 2 This region contains proliferating cells that evaginate laterally from the diencephalon. The budding tissue grows until it reaches the overlying ectoderm, whereupon it invaginates, giving rise to both the light-sensing neural retina and the light-absorbing retinal pigmented epithelium (RPE). These early eye field cells have interchangeably been called, "retinal progenitor cells" and "retinal stem cells". Stem cells have classically been defined as cells that can generate new stem cells, as well as a variety of differentiated cell types; progenitor cells are more restricted, generating a minimal population of new progenitor cells and forming only a restricted set of cell types. 3 Therefore, in this review, we will refer to the cells in the developing eye field, as retinal progenitor cells. In adult chicken, fish and amphibian eyes, proliferating cells are located in the periphery of the retina in a region called the ciliary marginal zone (CMZ). As these animals grow, the CMZ cells contribute to retinal tissue growth, adding newly differentiated cells. 4 We will refer to these as retinal stem cells, as they continually generate copies of themselves while contributing differentiated cells to retinal growth.
JOURNAL OF The search for retinal stem cells in the mammalian retina led to the finding of quiescent ciliary epithelial cells in both adult murine and human retinas. When cultured, these cells could be clonally expanded and formed neurospheres. 5, 6 While these cells were highly celebrated upon their discovery, closer examination has revealed that they maintain characteristics of their pigmented cellular origins when they are cultured. In fact, when meticulously examined by electron microscope analysis, each cell within a given neurosphere maintains ciliary epithelial morphology and its characteristic pigmentation. Furthermore, these ciliary epithelial cells fail to fully differentiate into retinal cells and express retinal markers, either in culture or when transplanted into the permissive newborn subretinal space. 7 The evidence suggests that ciliary epithelial cells can proliferate in culture under certain circumstances, yet the conditions to transdifferentiate them into retinal cells remain unknown. Although initially an attractive hypothesis, this further suggests that the CMZ, and its potential source of stem cells, appear to have been lost in mammals. On the other hand, understanding the mechanism used by lower vertebrates to maintain this retinal stem cell population may give us clues towards understanding how to recover this potential sight saving process in humans. 8 Another potential source of retinal cells for retinal repair could be the RPE which forms a monolayer of cuboidal, pigmented cells behind the retina. In amphibians, fish and embryonic birds, removing the retina activates a repair mechanism that stimulates the RPE to regenerate an entirely new retinal tissue. 9, 10 During this process, the newly formed neuroepithelium loses pigmentation and begins to proliferate and differentiate into a tri-layered retina. This process does not occur in higher vertebrates. However, if RPE cells are removed from a human retina and are allowed to grow in culture, a subset of these cells will proliferate. When differentiated, these cells generate new RPE or mesenchymal cells. 11 The conditions to transdifferentiate these cells into retinal cells has not been discovered, nevertheless, generating RPE cells from pluripotent human embryonic stem cells has already been demonstrated. [12] [13] [14] Slightly modified conditions are required to generate retinal progenitors from pluripotent stem cells.
gEnEtiC nEtwoRK REgulAting REtinA foRmAtion
The genetic network that drives retinal figure 1. Schematic of eye development in frog, mouse and human; the eye develops from cells in the anterior neural plate and is drawn in blue throughout all stages of development. The optic vesicle schematic is a cross-section of the embryo, showing the eye bud. Retinal progenitor cells (RPCs) are found in the optic cup after evagination. The retinal cells are born in order shown from left to right.
GC, ganglion cell; hz, horizontal cell; BP, bipolar cell; Müller, müller glia specification was originally discovered in fly when the genes required for eye specification were shown to be expressed at the same time and place for eyes to form. 15 These genes are part of the Retinal Determination Gene Network (RDGN) 16 and regulate each other's expression. Surprisingly, similar to the fly eye, we discovered a vertebrate eye specification network regulated by the eye field transcription factors (EFTFs Similar observations were made by another group, in which they revealed that low Noggin concentrations yielded brain tissue, while high concentrations exclusively made retina. 19 Noggin is a bone morphogenetic protein (BMP) antagonist. Repression of BMP signaling, along with Wnt signal repression, is required for neural versus epidermal cell fate. 20 Recently, Bayramov has represented that the more potent, Noggin2, can inhibit BMP, Activin/Nodal and Wnt signaling in the anterior neural plate to affect forebrain specification during late gastrulation. 21 It is unclear whether or not the generation of functional eye tissue uses a similar mechanism.
When performing our transplantation studies, we also noticed that dosage could affect the efficiency with which the transplanted eye tissue was generated. Each EFTF had to be injected at the optimal concentration in order to provide the maximal number of host animals with EFTF-induced retinal cells. Mice with null mutations in EFTF genes may unveil which EFTF are needed at higher versus lower concentrations. For example, in double mutants, loss of Otx1 (null mutant) and lower levels of Otx2 (+/-) can be rescued by adding back one copy of either Otx1 or Otx2. 22 When comparing Pax6 mutant phenotypes, a correlation was found between Pax6 activity level and eye formation; mice with Pax6 activity level of 50% have small eyes while those with no Pax6 have no eyes.
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Six3 heterozygotes have defects in just forebrain development while Six3-null littermates, lack entire forebrain and eyes. Decreasing levels of Six3 expression coincided with a gradual increase in Wnt1 transcript induction, a crucial signal that needs to be repressed during normal eye formation. 24 Interestingly, Rax/Rx1, Lhx2 and Six6 heterozygous mice develop normal looking eyes while null mutants have eye defects, suggesting that the transcript levels produced by one allele for these genes is sufficient for normal eye development. [25] [26] [27] Future work could unravel a new genetic network that describes both the genetic interactions and thresholds necessary for each regulatory event. This could lead to better understanding of how retinal progenitor cells are derived from pluripotent cells.
gEnERAtion of REtinAl PRogEnitoR CEllS
Investigators who studied early embryonic development in Xenopus knew the importance of BMP repression for neural cell formation and were eager to test mouse embryonic stem (ES) cells with this protocol. Unexpectedly, attempts to directly repress BMP signaling by adding Chordin, Follistatin, or a dominant negative BMP receptor to mouse ES cells, failed to even generate TuJ-positive neural cells. A more successful approach for inducing neurons in ES cell cultures was applying the stromal cellderived inducing activity (SDIA) method, a term coined by the Sasai lab ( Fig. 2A) . 28 In this method, bone-marrow derived stromal cell line, PA6, provide unknown factors to the ES cells cocultured over them. A variation of this protocol (co-culturing mouse ES cells with stromal cells and then treating with basic fibroblast growth factor (bFGF), dexamethasone, and cholera toxin) led the cells to adopt the characteristic morphology of RPE and express markers for retina and lens cells (Fig. 2B ). These markers were not induced in ES cultures derived from Pax6 null-mutant mice with anophthalmia. 29 When transplanted into a chick embryonic eye, these cells formed RPE-like monolayers, and expressed a marker for early-born retinal ganglion cells (TuJ-1). 30 Co-culturing with adult CT, cholera toxin; RA, retinoic acid; LIF, leukemia inhibitory factor; FCS, fetal calf serum; DKK-1, Dickkopf WNT signaling pathway inhibitor 1; IGF-1, insulin-like growth factor 1; bFGF, basic fibroblast growth factor; ESCM, embryonic stem cell media; Retinal diff media, retinal differentiation media mouse retinal explants in which ganglion cells were chemically damaged, the ES-derived cells migrated across all layers, settled in the ganglion cell layer, and expressed markers for retinal ganglion cells. 31 By combining the stromal cell culture method with retinoic acid (RA) treatment and Rx/Rax overexpression, the treated ES cells migrated into retinal explants and convincingly expressed markers for horizontal cells (Fig. 2C) . 32 Nevertheless, the SDIA method had its limitations. While lens could also be formed in both mouse and non-human primate cell cultures, 33, 34 it was discovered that the SDIA method preferentially induced midbrain dopaminergic neurons and only a low level of markers for telencephalic neurons. 35 An alternative, serum-free culture method was discovered to give rise to neural precursors in over half of the cultured mouse ES cells. The cells carried a transgene for the promoter of the early neural marker, Sox1, driving green fluorescent protein (GFP) expression. Fluorescent neural precursors could be fluorescence activated cell for FAC (FAC sorted) for higher purity and then studied. 36 While screening for genes induced in Sox1-positive cells, a Wnt antagonist, i.e. secreted frizzled-related protein-2 (SFRP2), was uncovered. 37 Nodal signaling was also found to repress neural differentiation of mouse ES cells while Nodal antagonists promoted neuroectoderm formation in human ES cells. 38, 39 Years before, it was discovered that an inducer of head formation, Cerberus, repressed three signaling pathways in early head formation: Wnt, BMP and Nodal. 40 Yet, by repressing just Wnt and Nodal signaling in culture, telencephalic precursors were generated from mouse ES cells. 41 Further adaptation and refinement of this protocol in mouse ES cultures led to the generation of retinal progenitors that were Rx and Pax6 positive (Fig. 2D) . 42 The physical environment of the culture was also determined to play a role. When ES cells were forced to come in close contact and form embryoid bodies (EBs), greater than half the cultures expressed cortical cell markers. The EBs launched the process by forming hollow spheres, then the spheres collapsed on themselves and formed neural rosettes by the end of the week. 20 The pinnacle of success has been the recent generation of an entire optic cup in culture. By adding matrigel or pure extracellular matrix proteins, laminin and entactin, with Nodal and over the course of a week, optic cup structures were formed from the walls of the EB cultures. Remarkably, the optic cup could evaginate and invaginate on its own, without the benefit of the overlying lens, surface ectoderm and surrounding mesenchyme. The invaginated optic cup formed not only expressed markers for both RPE and neural retina but also the trilayered structure characteristic of this tissue. 43 This remarkable advance could lead the way to understanding early steps in mammalian eye formation that were difficult to determine since the eyes develop in utero.
mouSE VERSuS humAn EmBRyoniC StEm CEll CultuRES
Mouse and human ES cells are derived from the blastula at slightly different stages of embryonic development. 44 Whereas mouse ES cells proliferate in the presence of leukemia inhibitory factor (LIF) and are derived from the inner cell mass of the blastula, human ES cells proliferate in media containing Activin/ Nodal and bFGF, and seem to arise from a slightly later cell fate, the epiblast. 45 Therefore, it is not surprising that slightly different conditions were necessary for generating retinal progenitor cells from human and mouse cells. For example, mouse ES cells were unresponsive to the neuralizing effects of BMP antagonists (as stated above), yet human ES cells briefly treated with Noggin, and then continually cultured in epidermal growth factor (EGF) and bFGF, produced neural cells within 4 weeks of culture. In these cells, semi-quantitative polymerase chain reaction (PCR) showed expression of the EFTFs and photoreceptor-specific genes. Even so, proteins for these markers were not detected and transplantation into retina failed to produce photoreceptors with outer segments. 46 Treating human ES cell embryoid bodies for three days in low concentrations of Noggin, Wnt-inhibitor, Dickkopf WNT signaling pathway inhibitor 1 (Dkk-1), and insulin-like growth factor 1 (IGF-1) then switching to higher amounts and plating on Matrigel for 7 to 21 days, caused the ES cells to express transcripts for EFTFs and photoreceptorspecific genes (Fig. 2E) . 47 Transplanting these cells into neonatal mouse retinas produced cells with photoreceptor morphology, including outer segments. 48 Human ES cells have a natural capacity to form a subset of anterior neuroepithelial cells. In this way, an alternative approach to adding extrinsic factors was discovered by the Gamm lab. They selected rosette-forming cells at day 16, cultured these cells and found greater than 95% expressed Rx and Pax6 (Fig. 2F) . Interestingly, both Dkk1 and Noggin were detected in these cells by Western blotting, while adding Wnt3A and BMP4 to the cultures stopped Rx and Pax6 expression. Cells with characteristic RPE morphology and RPE gene expression were detected in these cultures, as were cells expressing photoreceptor-specific proteins. 13 The ability to form retinal cells from human ES cells has been a great advance toward generating a population of cells useful for cell replacement therapy. Both the Gamm and Sasai labs have revealed that they can generate laminated retinas using either pluripotent iPS or ES cells. 49, 50 The human ES-derived eye cups could be frozen down and later, thawed and re-cultured. 49 This is the first step in generating populations of cells for the clinic. Many studies are now focused on biasing these cells toward a homogenous culture of one retinal cell type.
gEnERAtion of PhotoRECEPtoR AnD gAnglion CEllS fRom mAmmAliAn EmBRyoniC StEm CEll CultuRES
Generation of photoreceptors has been of particular interest, since photoreceptor cell degeneration is the primary cause of blindness in retinitis pigmentosa and age-related macular degeneration; two diseases that affect a growing number of Americans. Intrinsic transcription factors that guide photoreceptor formation have been recently reviewed. 51, 52 Therefore, we will focus on extrinsic factors that induce photoreceptor formation.
The involvement of Notch signaling in photoreceptor formation was first discovered when interference of this pathway in retinal progenitors caused photoreceptor cell increase in the Xenopus retina. 53 Consistent with this finding, photoreceptor cells were also predominantly increased when Notch1 was removed from the developing mouse and chick retina. [54] [55] [56] When indirectly inhibiting Notch signaling in ES cell cultures by treating with the γ-secretase inhibitor IX, DAPT, the Takahashi lab discovered that photoreceptor-specific transcripts and protein could be induced in ES cell culture from mouse, monkey and human 57 . Similarly, when human ES-derived eye cups were treated with DAPT, there was a large increase in the number of cells expressing the cone-rod homeobox (Crx) marker, suggesting that photoreceptor cells were increased within these cultures. 49 In addition to removing Notch, the Takahashi group also tested a variety of growth factors that were shown previously to promote rod photoreceptor formation in the embryo (Table 1 ; reviewed by Levine, 2000) 66 . These factors were tested on mouse ES cells treated by the serum-free floating culture of embryoid body-like aggregates (SFEB) combined with treatment with Dkk1, left-right determination factor 2 (LeftyA), fetal calf serum, and Activin (DLFA) (Fig. 2D) . Adding factors shown in Table  1 , they found rod photoreceptor cell production increased from 5% to 17% of the total Rx-positive cells grown in adherent cultures. For monkey and human ES cell cultures, they found that Dkk1 and LeftyA treatment of floating ES cultures was necessary after SFEB treatment. Besides, taurine and retinoic acid were the only factors necessary for inducing 12% rhodopsin-positive cells in monkey and about 9% rhodopsinpositive cells in human cultured ES cells. Cone photoreceptors (red/green cones and blue cones) were also found at similar percentages, making the total number of cells generated into photoreceptors approximately 25-35%. 57 It is interesting to note that similar percentages of ES-derived photoreceptors were found after co-culturing the ES-derived Rx/Pax6-positive cells with E17.5 retinal cells. 42 This suggests that the factors used in the study by Osakada et al 57 are as effective as the factors produced by the embryonic retina.
Other factors have also been implicated in coaxing retinal progenitor cells toward photoreceptors (green rows, Table 1 ). Retinoic acid (RA) treatment produces different results by its two isomers. While all-trans retinoic acid treatment results in 10 times as many rods in retinal progenitor cultures as controls, 9-cis retinoic acid treatment results in 25 times as many rods with one fifth of the concentration (100 versus 500 nanomolar). 62 Increasing Activin signaling (adding Activin A) has also been demonstrated to promote rod photoreceptors in retinal progenitor culture, while the Activin-βA knockout mouse has fewer photoreceptors. 64 Thyroid hormones (like T 3 ) have been demonstrated to be important for regulating cone opsin expression. Thyroid hormone receptor beta isoform 2 protein was first found in retinal progenitor cells shortly after mouse cone genesis. 67, 68 In mice with a null-mutation in either thyroid receptor β2 (TRβ2) or retinoid X receptor gamma (RXRγ), S-opsin was universally expressed in all cones, instead of their usual dorsal to ventral, low to high expression gradient. 69, 70 These factors (RA, Activin A, T3, along with Taurine and Shh) were used to promote photoreceptor formation in human ES cultures incorporating these factors into the RD method (Fig. 2E) . At 45 days, the cells reached a peak percentage of S-opsinpositive cells (52%), yet dropped to ~4% S-opsinpositive by day 60, suggesting that conditions to maintain these cells in culture still needs to be discovered. 71 Retinal ganglion cell production from ES cell cultures has also been reported. In one study, mouse ES cells were transfected with a neomycin-resistant, Pax6-expressing plasmid. Cells were selected for their ability to induce six3, shh and ganglion cell specific transcripts. Transplantation into the mouse renal capsule showed neural-like processes. 72 Using these cells for cell replacement therapy will be quite a challenge since the healthy donor cells would have to integrate and not only establish correct synaptic connections inside the retina, but also navigate outside the retina to make proper connections in the brain. Optimal concentration was reported in the reference listed on cultured retinal progenitor cells. The last two columns (red) show successful concentrations reported by Osakada et al, 57 in mouse, monkey and human embryonic stem (ES) cell cultures, while the green rows are factors reported only by other studies. DAPT, γ-secretase inhibitor IX; aFGF, acidic fibroblast growth factor; bFGF, basic fibroblast growth factor; Shh, sonic hedgehog; Alltrans RA, all-trans retinoic acid; 9-cis RA, 9-cis retinoic acid; T3, triiodothyronine (active thyroid hormone) All iPS cell lines are not the same; some lines express higher neural markers than others. To generate retinal cells, the Gamm lab chose an iPS line known to express high levels of Pax6 and used these in their default method to generate retinal progenitor cells. 13 Other iPS cell lines, with lower neural potential, were used by carefully selecting for an optic vesicle-like structure during the differentiation protocol. Using this approach, iPS-derived RPE cells were generated from a gyrate atrophy patient; a genetically heterogeneous disease. In gyrate atrophy patients, blindness is primarily due to a defect within the RPE. The cultured RPE cells, generated by this method, were tested for their response to levels of pharmacological agents that could treat the retinal disease. By understanding how the affected cells respond to treatment in a Petri dish, physicians could more effectively treat patients with appropriate concentrations of drugs and treatment paradigm for that individual. 14 Patients with retinitis pigmentosa, which primarily affects rod photoreceptor cells, would also benefit from first testing iPS-derived rod photoreceptors in the dish, but first the conditions to generate these cells should be defined.
gEnERAtion of REtinAl CEllS fRom inDuCED PluRiPotEnt CEllS
In order to maximize photoreceptor production, the human iPS cell line, IMR90-4, was studied over other available human iPS cell lines because the 'default method' of differentiation caused the formation of Pax6-positive cells by culture day 10 (Fig. 2F) . Growing these cells to day 80 using this method, the authors found that 14% of all colonies expressed the early photoreceptor marker, Crx. 13 The same percentage of Crx-positive cells were found at day 80 when human iPS cells were cultured using the SFEB/DLFA method (Fig. 2D) . These culture conditions yielded Rx-positive colonies that were frequently also expressing an early marker for RPE progenitors, Mitf. Treating these cells with retinoic acid and taurine, increased Crx expression, and induced later photoreceptor markers, Recoverin and Rhodopsin. 73 Crxpositive cells (23%) were also induced in mouse iPS cell lines by first putting them through a neural induction protocol and then exposing the cells to rat retinal P1 (PN1CM) or rat retinal E14 conditioned media (E14CM). Interestingly, the age of the conditioned media biased the retinal cells to form age-corresponding cells; that is, E14CM induced early-born, cone and ganglion cell markers, while PN1CM promoted late-born, rod and bipolar cell markers. 74 In order to further favor photoreceptor formation, human iPS cell lines were tested for the highest increase in Crx after culturing by applying the RD method of retinal induction (Fig. 2E ). These cells were infected with a photoreceptor-specific promoter driving GFP expression [interphotoreceptor retinoid-binding protein (IRBP) >GFP] during the culture period. Once a substantial number expressed GFP (10%), the cells were FAC sorted and transplanted into adult wild type mice eyes to be tested for integration. While a few cells integrated into the photoreceptor layer, none were found growing a morphologically characteristic outer segment. 75 All iPS cell lines used in the above studies were derived from human or mouse fibroblast cells. A different approach used blood cells (T-lymphocytes) to derive an iPS cell line. Again, using the 'default method,' the authors generated retinal cells from T-lymphocytederived human iPS cells (TiPSCs). These TiPSCs formed optic vesicle-like spheres, just as when ES or iPS-derived from fibroblasts were employed. Some neurospheres were observed to have a laminated structure with photoreceptor-specific markers expressed in cells on the outer rim and ganglion-specific marker cells on the inner rim of the sphere. 50 The ability to generate retinal cells from easily accessible blood cells is a great step toward developing protocols for clinical use. Other pluripotent cell sources have not been as successful. In a recent study, amniotic fluid-derived stem cells were collected from three different lines of mice: two expressing GFP under the control of photoreceptor-specific promoters (Nrl>GFP and Crx>GFP), and one line expressing GFP driven by a retinal progenitorspecific promoter (Fgf15>GFP). After culturing amniotic cells from each of these mice using the SFEB/DLFA method (Fig. 2D ) and growing them on mouse retinal explants, these cells failed to differentiate into retinal cells did not express GFP. 76 Therefore, it is important that these cells be tested for their ability to function in the retinal environment that the cells would repair.
tRAnSPlAntAtion StuDiES to VERify funCtion/fEASiBility of CEll REPlACEmEnt
The ability of cultured cells to integrate, form connections and morphologically resemble retinal cells adds evidence that cultured cells are forming bonafide retinal cell types. The ES-derived eye-like cells induced in stromal cultures were transplanted but failed to integrate and differentiate in the adult mouse retina (Fig. 2B) . 77 Upon ganglion cell damage [induced by N-methyl-D-aspartate (NMDA) injection], the ganglion-like cells from these culture integrated into an adult eye, yet host animals failed to produce a vision evoked response. This suggests that these cells were not able to replace lost ganglion cells. 77 In another study, ES cells treated with retinoic acid for four days were transplanted into the vitreous of retinal degeneration mice (rd1). These cells partially migrated into the retina and expressed neural cell markers but failed to differentiate into morphologically characteristic retinal cells. 78 Using dissociated retinal progenitors from transgenic mice expressing GFP in rod progenitors (Nrl>GFP), it was determined that cells already specified toward a rod cell fate had the best integration rate and formed remarkably characteristic outer segments in the adult wild type retina. This study proposed that the developmental age of the donor cell should be considered, since much younger retinal progenitors failed to integrate as well as their postnatal counterparts. 79 With this in mind, cone progenitors were isolated from earlier developmental stages. In order to perform this, FAC sorted Crx-positive cells were isolated at developmental stages that would favor the isolation of cone over rod progenitors (E12.5, E14.5 and E15.5). Surprisingly, when these donor cells were transplanted into the wild-type retina, many failed to integrate. The peak amount of cones (10 integrated cells) was observed from the E14.5 donor population. 80 These results suggests that cone progenitors are still very rare and the number of these cell types needs to be favored for more robust number of integrated cells.
Retinal cells derived from mouse ES cells by the SFEB/DLFA method (Fig. 2D) were characterized for their expression of pluripotent markers and markers of early and late photoreceptor-specific expression. NRL-positive cells were infrequently found (0.2%) while the transcript for crx, nrl, nr2e3 and rhodopsin were all present in these cells. Transplantation of cultured cells at peak NRL expression (day 28), which were 60% Crx-positive, failed to integrate and formed tumors. 81 This suggests that the expression profile of the cells may not be an indicator of proper integration and potential retinal repair. However, cell surface markers for photoreceptor progenitor cells may be a better indicator. Sorting developing retinal cells using antibodies against CD24 and/or CD73, the same investigators found an increase in integration (18-fold) over the unsorted retinal cells of the same developmental age. 82 This presents an exciting new way of isolating cultured retinal cells from pluripotent cell sources. Retinal cells from all different culture methods could be sorted using these two commercially available antibodies and tested in future transplantation studies.
One problem with transplanting individual cells is that they form rosettes because apical and basal cues are lost in the microenvironment. One way around this problem would be to create a three-dimensional scaffold that would provide the orientation in vitro, prior to transplantation. Dissociated mouse retinal progenitors and human ES cells put through the RD protocol were grown on a three-dimensional polylacticco-glycolic acid (PLGA) scaffold, designed to support the columnar organization characteristic of differentiating retinal progenitor cells. Both mouse and human cells aligned themselves in a pattern consistent with their location in the developing retina; that is, Pax6-positive cells lined up above Otx2-positive retinal cells. 83 been successfully transplanted in the subretinal space. The cells were first grown on a 4 micron parylene substrate and then injected in the rat eye. Only 2% of the transplanted cells were lost using this technique. 84 Future studies could combine these two cultures to create an entirely new retina in culture, ready for transplantation.
ARtifiCiAl REtinA
Recent excitement has surrounded the retinal prosthesis field. Patients with advanced stages of retinitis pigmentosa were again able to recognize letters and words. The 60-electrode, Argus II epiretinal prosthesis was surgically fitted on top of their inner limiting membranes to stimulate remaining retinal ganglion cells. The patients receiving this device were then tested for letter recognition. Of the 30 subjects, six were able to correctly identify letters and even words after surgery. 85 An alternative 16-electrode array has been developed by Zrenner's group in Germany, called the Tübingen array. Rather than intravitreal placement, surgeons implant the 16-electrode array in the subretinal space, in an effort to stimulate remaining bipolar and ganglion cells. Of the 11 patients treated, 8 were able to process electrical stimulation as visual images. 86 These prosthetic devices hold great promise as the arrays become more sophisticated and the costs become more affordable ($150,000/ implantation in the US). 87 Retinal prosthesis may be another option to repair damaged or degenerating retinas.
